Investors

Expedeon Introduces Lightning-Link Rapid Bioconjugation Kits

November 3rd, 2014

New kits enable customers to conjugate primary antibodies in 20 minutes Cambridge, UK, 3rd November 2014: Expedeon (Innova), a specialist provider of bioconjugation products and services, announced today the launch of new antibody and protein labelling kits within its Lightning-Link® Rapid range. These kits enable researchers to label primary antibodies or other proteins in just…

View